Salim Yazji - 12 Apr 2023 Form 4 Insider Report for Oncternal Therapeutics, Inc.

Role
Chief Medical Officer
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
12 Apr 2023
Net transactions value
+$7,200
Form type
4
Filing time
14 Apr 2023, 18:02:10 UTC
Previous filing
23 Feb 2023
Next filing
05 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Purchase $2,850 +10,000 +7.2% $0.2850 149,676 12 Apr 2023 Direct
transaction ONCT Common Stock Purchase $2,850 +10,000 +6.7% $0.2850 159,676 13 Apr 2023 Direct
transaction ONCT Common Stock Purchase $1,500 +5,000 +3.1% $0.3000 164,676 14 Apr 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.